Home/ Supplements/ Vitamin K/ Vitamin K2 100 mcg

Vitamin K2 100 mcg

product on market Softgel Capsule Sports Research Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is supported by moderate evidence for promoting calcium deposition in bones and preventing arterial calcification. Research indicates it works synergistically with Vitamin D to maintain skeletal health. This ingredient profile is generally considered safe for most healthy adults.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veggie Softgel(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Coconut Oil, Virgin Tapioca Starch, Modified Glycerin Water, Purified Rice Bran Wax
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take 1 veggie softgel daily with food, or as recommended by a qualified healthcare professional.

Warnings & Precautions

Caution: Keep out of reach of children and pets.

Consult with a qualified healthcare professional prior to using this product, especially if you are pregnant, nursing, have a diagnosed medical condition, or are taking a prescription medication (e.g., Anticoagulants [Coumadin/Warfarin]).

Do not exceed recommended daily intake. Do not use if safety seal is damaged or missing.

Contains: Tree nuts (coconut).

Formulation Notes

Quality matters: Third party tested cGMP compliant

Certified Vegan vegan.org

Non-GMO verified Gluten-free

Plant-based Supports bone & immune health

Vitamin K2 100 mcg per serving with coconut oil

Vegan

Gluten-free

Proudly manufactured in the USA with carefully selected ingredients of domestic and international origins.

Additional Information

Non GMO Project Verified nongmoproject.org Certified Vegan vegan.org

Store at room temperature, in a dry place. Protect from excessive heat, freezing, humidity and light.

2 HDPE Non BPA Please recycle Scan for more

Metadata

Product Details

UPC / SKU0 23249 00439 4
DSLD Entry Date2025-01-23
Product TypeVitamin
FormSoftgel Capsule
DSLD ID326303
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.